# Acurx Pharmaceuticals, Inc.: Form 8-K, filed Jun 20, 2025

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: 8-K
- Filed: 2025-06-20
- Accepted by EDGAR: Jun 20, 2025, 08:00 ET
- Period: 2025-06-17
- Accession: 0001104659-25-060902
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/tm2518285d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/tm2518285d1_8k.htm

Filed Jun 20, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-060902. Last ingested by Listed: Oct 29, 2026, 17:22 ET. No prices; not investment advice.